Tamoxifen - Bone Marrow and Peripheral Blood Stem Cell

Essential information

Obligatory

See: Maligancy

Discretionary

Less than 12 weeks after completion of treatment with tamoxifen – refer to designated clinical support officer.

Supporting information

See if relevant

• Infertility

Reason for change:

To clarify that use of Tamoxifen for non-malignant conditions is not a contraindication to donation.

Version details:

BM-DSG Edition 203 Release 38 (07 October 2020)